Stay updated on Nemolizumab Efficacy in Atopic Dermatitis Clinical Trial

Sign up to get notified when there's something new on the Nemolizumab Efficacy in Atopic Dermatitis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nemolizumab Efficacy in Atopic Dermatitis Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    An NIH-wide notice about the transition from “Artificial Intelligence” to “Super Intelligence” appears above the 403 error page, and the site revision number is updated.
    Difference
    1%
    Check dated 2026-10-20T22:53:21.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    The site footer revision changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-07T00:28:29.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error instead of the study content, replacing the original record view with a standard error page. The site chrome (navigation and footer) remains visible, indicating an access restriction rather than a content update.
    Difference
    0.5%
    Check dated 2026-09-30T00:09:01.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, replacing the study record content. This blocks access to the trial's details and presents a Home option for navigation.
    Difference
    17%
    Check dated 2026-09-23T01:02:41.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    Revision: v3.7.0 appears, replacing the previous Revision: v3.6.6. This reflects a minor update to the page's revision history without altering substantive content or functionality.
    Difference
    0.0%
    Check dated 2026-09-16T00:16:14.000Z thumbnail image
  7. Check
    46 days ago
    Change Detected
    Summary
    A new publication reference by Liu D et al., Tape Strip Transcriptomics Reveal Nemolizumab Effects on Pruritus, Hyperplasia, Inflammation, and Extracellular Matrix Markers in Patients With Moderate-to-Severe Atopic Dermatitis, Allergy. 2026 Sep 4, doi: 10.1111/all.70505, was added to the Publications section.
    Difference
    0.0%
    Check dated 2026-09-08T22:50:32.000Z thumbnail image

Stay in the know with updates to Nemolizumab Efficacy in Atopic Dermatitis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nemolizumab Efficacy in Atopic Dermatitis Clinical Trial page.